Mergers, Acquisitions Divestitures and Restructurings

• Sale of equity interest in Vince and Associates Clinical Research, a clinical services business, to Celerity Partners
  
  
• Sale of Alliance Healthcare Information, a healthcare communications and medical affairs company, to United Drug
  
  
• Sale of ARS Clinical Research, a contract research and data management business, to Premier Research Group
  
  
• Sale of ValueMedics Research, a healthcare research and consulting firm, to IMS Health
  
  
• Sale of California Clinical Trials, a clinical services business, to PAREXEL International
  
  
• Sale of Lineberry Research Associates, a contract research organization, to Constella Group
  
  
• Acquisition of Doral, MedPointe's pharmaceutical product, by Questcor Pharmaceuticals
  
  
• Acquisition of Gastrocrom, UCB's pharmaceutical product, by Azur Pharma and Burren Pharmaceuticals
  
  
• Strategic and financial advisory to Prologue Research, an oncology-focused contract research organization
  
  
• Sale of Nascobal, Questcor Pharmaceutical’s product line to
  QOL Medical
  
  
• Licensing of oxcarbazepine MR, Desitin Arzneimittel’s late-stage CNS pharmaceutical product to a leading U.S. specialty pharmaceuticals company
  
  
• Sale of the Twinject, Hollister-Stier Laboratories’ allergy product, to Verus Pharmaceuticals
  
  
• Sale of MedSN, a pharmaceutical education and marketing company, to Indegene
  
  
• Product valuation, license structuring and strategic / financial advisory services to Anosys, Inc.
  
  
• Licensing MT-300, POZEN’s pharmaceutical product line, to Xcel Pharmaceuticals
  
  
• Sale of Nascobal, Nastech Pharmaceutical Company’s pharmaceutical product line, to Questcor Pharmaceuticals
  
  
• Sale of PharmAnalysis Group, a provider of reimbursement support services, to United Biosource Corporation
  
  
• Strategic and financial advisory to Scion Companies / Prasco, a private specialty pharmaceutical company
  
  
• Sale of CroMedica International, a Central Nervous Systems drug development contract research organization, to PRA International
  
  
• Acquisition of Richwood Pharmaceuticals by Shire Pharmaceuticals, a public U.K. based pharmaceutical company
  
  
• Acquisition of Pharmavene by Shire Pharmaceuticals, a public U.K. based pharmaceutical company
  
  
• Sale of Warner Chilcott, Warner Lambert’s generic pharmaceuticals business, to a buyout group
  
  
• Sale of Quinton division of American Home Products, a leading cardiac testing equipment manufacturer, to a buyout group
  
  
• Strategic and financial advisory to Simstar Internet Solutions, a pharmaceutical marketing services company
  
  
• Sale of Clinsoft (Domain Pharma), a clinical trials data management software provider to PhaseForward
  
  
• Sale of Kelly Waldron & Co., a pharmaceutical marketing services provider, to McKesson
  
  
• Acquisition of Kelly Waldron, a pharmaceutical marketing services provider, by McKesson
  
  
• Acquisition of SFA, a technology company focused on pharmaceutical sales force automation, by McKesson
  
  
• Sale of Healthworld, a leader pharmaceutical marketing services provider, to Cordiant Communications
  
  
• Sale of Covance’s biomanufacturing division to Akzo Nobel
  
  
• Sale of Worldwide Clinical Trials, a leading Central Nervous Systems drug development contract research organization, to the Ingenix division of United Health Group
  
  
• Sale of Horizon Systems, a pharmaceutical sales data integration firm, to Acxiom Corporation
  
  
• Sale of Storz Ophthalmic division of American Home Products, a leading ophthalmology equipment manufacturer, to Bausch & Lomb
  
  
• Merger of Behring Diagnostics division of Bayer, Inc. with Dade Corporation
  
  
• Acquisition of HBOC, the largest healthcare information technology provider, by McKesson
  
  
• Recapitalization of stock and assets to form iMcKesson, LLC by McKesson
  
  
• Sale of Medstat, a health claims data company, to Thomson Corporation
  
  
• Acquisition of Medivation, an Internet company focused on structured clinical messaging, by McKesson
  
  
• Acquisition of Prospective Health, a technology company focused on electronic transaction software, by McKesson
  
  
• Acquisition of Abaton.com, an Internet company focused on clinical connectivity, by McKesson
  
  
• Divestiture of McKesson Water Products division of McKesson to Group Danone
  
  
• Sale of US Servis, a public healthcare information technology company, to HBOC
  
  
• Sale and Recapitalization of Hemophilia Resources of America (HRA), a hemophilia factor and supplies specialty pharmacy distributor, with Summit Partners
  
  
• Acquisition of OCMCS by FPA Medical Management, a public physician practice management company
  
  
• Sale of Physicians Corp. of America (PCA), a physician practice management company, to Humana
  
  
• Acquisition of Preferred Provider of Michigan (PPOM) by Blue Cross Blue Shield of Michigan
  
  
• Leveraged buy-out of Healthcare Direct, a leading mail order personal and health products company, by an investor group
  
  

Equity & Debt Capital Raising

• Valuation and financial advisory services for Xanodyne Pharmaceuticals, Inc. in connection with its Series C financing
  
  
• Co-Manager, U.S. IPO for Shire Pharmaceuticals, a public U.K. based pharmaceutical company
  
  
• Co-Lead Manager, acquisition debt facility for Medpointe, a new company formed by senior pharmaceutical industry managers, The Carlyle Group and The Cypress Group to acquire the Carter Wallace pharmaceutical business
  
  
• Co-Agent Fixed Rate Swap for Medpointe
  
  
• Sole agent, $25 million private placement for BattellePharma, a drug delivery company
  
  
• Co-Manager, $2 billion Senior Notes Offering for American Home Products, a leading pharmaceuticals manufacturer
  
  
• Co-Manager, Follow-on Offering for Marquette Medical Systems, a leading capital diagnostic equipment manufacturer
  
  
• Co-Manager, Initial Public Offering, Physio-Control Corporation, the leading manufacturer of cardiac defibrillators
  
  
• Lead Manager, $150 million senior notes for Cardinal Health, the leading pharmaceutical distribution company
  
  
• Co-Manager, Follow-on Offering for Amerisource, a leading pharmaceutical distribution company
  
  
• Joint-Book Running Manager, $375 million senior subordinated notes issue for Omnicare, the leading institutional pharmacy company
  
  
• Co-agent, $495 million bank facility for Omnicare
  
  
• Lead Manager, Initial Public Offering for Boron, Lepore & Co., a leading pharmaceutical sales and marketing services company
  
  
• Lead Manager, Follow-on Offering for Boron, Lepore & Co.
  
  
• Lead Manager, Follow-on Offering for Quality Systems, a physician practice management software provider
  
  
• Comfort Letter, IPO for Mecon, a healthcare information technology company
  
  
• Lead Manager, Initial Public Offering for Access Worldwide, a pharmaceutical sales, marketing and fulfillment services provider
  
  
• Lead Agent, stock repurchase program for Quintiles Transnational, the leading CRO
  
  
• Sole Agent, block trade for Pharmaceutical Product Development Inc., a leading CRO
  
  
• Lead Manger, Follow-on Offering for Medcath, operator of specialized heart hospitals
  
  
• Lead Manager, $75 million convertible debentures for Penn Treaty Corp., the leading independent long term care insurance provider
  
  

Venture Capital

• Venture investment in WebMD and subsequent liquidation of position in the public equity market
  
  
• Venture investment in Pharsight, a pharmaceutical services company focused on clinical trial simulation software
  
  
• Venture investment in WellMed, an Internet company focused on personal medical records
  
  
• Venture investment in AvantGo, a technology company focused on middleware for mobile Internet devices
  
  
• Investment in Mediconsult.com, an Internet company focused on pharmaceutical marketing
  
  

Strategic Alliances

• Joint Venture with AvantGo, a technology company focused on middleware for mobile Internet devices
  
  
• Strategic partnership with Mediconsult.com, an Internet company focused on pharmaceutical marketing
  
  
• Technology partnership and equity stake in Claimsnet.com, an Internet company focused on electronic transactions